Trial Profile
CETUXIMAB IN COMBINATION WITH CISPLATIN PLUS DOCETAXEL TO EVALUATE THE ACTIVITY AND SAFETY IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA: PHASE II DOCETUX STUDY.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Jul 2011
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Acronyms DOCETUX
- 09 Jul 2011 New trial record